Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenji Sakuma

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Translational Psychiatry|December 19, 2022
Paliperidone palmitate vs. paliperidone extended-release for the acute treatment of adults with schizophrenia: a systematic review and pairwise and network meta-analysisTaro Kishi, Kenji Sakuma, Nakao Iwata
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|April 28, 2007
Short latency afferent inhibition is not impaired in mild cognitive impairmentKenji Sakuma, Takenobu Murakami, Kenji Nakashima
Psychopharmacology|December 7, 2018
Response to the Letter from Dr. Jacob PeedicayilKenji Sakuma, Taro Kishi, Nakao Iwata
Pharmacopsychiatry|July 5, 2022
Aripiprazole Once-Monthly Versus Oral Aripiprazole for Schizophrenia in the Maintenance Phase: A Systematic Review and Network Meta-AnalysisTaro Kishi, Kenji Sakuma, Nakao Iwata
Translational Psychiatry|June 28, 2022
Mitochondrial modulators for obsessive-compulsive and related disorders: a systematic review and meta-analysisTaro Kishi, Kenji Sakuma, Nakao Iwata
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|October 14, 2008
Somatosensory evoked potentials and high-frequency oscillations in athletesTakenobu Murakami, Kenji Sakuma, Kenji Nakashima
Pharmacopsychiatry|January 31, 2020
Efficacy and Safety of Psychostimulants for Alzheimer's Disease: A Systematic Review and Meta-AnalysisTaro Kishi, Kenji Sakuma, Nakao Iwata
International Clinical Psychopharmacology|September 11, 2023
Valbenazine for tardive dyskinesia: a systematic review and network meta-analysisTaro Kishi, Kenji Sakuma, Nakao Iwata
PCN Reports : Psychiatry and Clinical Neurosciences|June 13, 2024
Lemborexant for insomnia in adults with psychiatric disorders: A 1-week, open-label studyTaro Kishi, Kenji Sakuma, Makoto Okuya, et al.
Brain Stimulation|January 17, 2025
Sham response of schizophrenia and depression in intermittent theta burst stimulation trials: A meta-analysisTaro Kishi, Kenji Sakuma, Masakazu Hatano, et al.
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Translational Psychiatry|December 19, 2022
Paliperidone palmitate vs. paliperidone extended-release for the acute treatment of adults with schizophrenia: a systematic review and pairwise and network meta-analysisTaro Kishi, Kenji Sakuma, Nakao Iwata
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|April 28, 2007
Short latency afferent inhibition is not impaired in mild cognitive impairmentKenji Sakuma, Takenobu Murakami, Kenji Nakashima
Psychopharmacology|December 7, 2018
Response to the Letter from Dr. Jacob PeedicayilKenji Sakuma, Taro Kishi, Nakao Iwata
Pharmacopsychiatry|July 5, 2022
Aripiprazole Once-Monthly Versus Oral Aripiprazole for Schizophrenia in the Maintenance Phase: A Systematic Review and Network Meta-AnalysisTaro Kishi, Kenji Sakuma, Nakao Iwata
Translational Psychiatry|June 28, 2022
Mitochondrial modulators for obsessive-compulsive and related disorders: a systematic review and meta-analysisTaro Kishi, Kenji Sakuma, Nakao Iwata
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|October 14, 2008
Somatosensory evoked potentials and high-frequency oscillations in athletesTakenobu Murakami, Kenji Sakuma, Kenji Nakashima
Pharmacopsychiatry|January 31, 2020
Efficacy and Safety of Psychostimulants for Alzheimer's Disease: A Systematic Review and Meta-AnalysisTaro Kishi, Kenji Sakuma, Nakao Iwata
International Clinical Psychopharmacology|September 11, 2023
Valbenazine for tardive dyskinesia: a systematic review and network meta-analysisTaro Kishi, Kenji Sakuma, Nakao Iwata
PCN Reports : Psychiatry and Clinical Neurosciences|June 13, 2024
Lemborexant for insomnia in adults with psychiatric disorders: A 1-week, open-label studyTaro Kishi, Kenji Sakuma, Makoto Okuya, et al.
Brain Stimulation|January 17, 2025
Sham response of schizophrenia and depression in intermittent theta burst stimulation trials: A meta-analysisTaro Kishi, Kenji Sakuma, Masakazu Hatano, et al.
Pageof 10